A Randomized, Open-label, Multi-center Clinical Trial to Compare Efficacy and Safety of Cyclosporine-based and Switching Cyclosporine to Tacrolimus of Two Forms-based Immunosuppressive Therapy in Renal Transplant (KTx) Recipients
Latest Information Update: 07 Feb 2019
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
Most Recent Events
- 25 Nov 2015 Status changed from recruiting to discontinued according to the ClinicalTrials.gov record.
- 24 Oct 2014 New trial record